Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 29, Issue 8, Pages 1340-1352
Publisher
Oxford University Press (OUP)
Online
2020-04-01
DOI
10.1093/hmg/ddaa061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Huntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEURON
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
- (2019) Bryan Zeitler et al. NATURE MEDICINE
- CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset
- (2019) Jong-Min Lee et al. CELL
- The pathobiology of perturbed mutant huntingtin protein–protein interactions in Huntington's disease
- (2019) Erich E. Wanker et al. JOURNAL OF NEUROCHEMISTRY
- Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease
- (2018) Diego Luis-Ravelo et al. EXPERIMENTAL NEUROLOGY
- Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
- (2018) Jana Miniarikova et al. MOLECULAR THERAPY
- Selective autophagy as a potential therapeutic target for neurodegenerative disorders
- (2018) Aurora Scrivo et al. LANCET NEUROLOGY
- Therapeutic approaches to Huntington disease: from the bench to the clinic
- (2018) Nicholas S. Caron et al. NATURE REVIEWS DRUG DISCOVERY
- A role for autophagy in Huntington's disease
- (2018) Katherine R. Croce et al. NEUROBIOLOGY OF DISEASE
- Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington’s disease
- (2018) Rebecca Aron et al. Nature Communications
- Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
- (2018) Xiaoyun Xu et al. Scientific Reports
- Genetic modifiers of Mendelian disease: Huntington’s disease and the trinucleotide repeat disorders
- (2017) Peter A. Holmans et al. HUMAN MOLECULAR GENETICS
- PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model
- (2017) Alisia Carnemolla et al. Frontiers in Cellular Neuroscience
- The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
- (2017) Wojciech J. Szlachcic et al. Frontiers in Molecular Neuroscience
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice
- (2016) Ian H. Kratter et al. JOURNAL OF CLINICAL INVESTIGATION
- Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease
- (2016) Eduardo E. Arteaga-Bracho et al. NEUROBIOLOGY OF DISEASE
- Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics
- (2016) Jing Jin et al. NEUROMOLECULAR MEDICINE
- Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
- (2016) Guohao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Subcellular Clearance and Accumulation of Huntington Disease Protein: A Mini-Review
- (2016) Ting Zhao et al. Frontiers in Molecular Neuroscience
- Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion
- (2015) Caroline Mauvezin et al. Autophagy
- Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
- (2015) Jong-Min Lee et al. CELL
- Neuronal Aggregates: Formation, Clearance, and Spreading
- (2015) Junghyun Lim et al. DEVELOPMENTAL CELL
- Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease
- (2015) Jing Jin et al. HUMAN MOLECULAR GENETICS
- Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy
- (2015) Tiffany W Todd et al. eLife
- The Differential Profiling of Ubiquitin-Proteasome and Autophagy Systems in Different Tissues before the Onset of Huntington's Disease Models
- (2014) Lu-Shiun Her et al. BRAIN PATHOLOGY
- Huntingtin-lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing
- (2014) Neil Aronin et al. MOVEMENT DISORDERS
- The role of protein clearance mechanisms in organismal ageing and age-related diseases
- (2014) David Vilchez et al. Nature Communications
- Ubiquitin–proteasome system involvement in Huntington’s disease
- (2014) Zaira Ortega et al. Frontiers in Molecular Neuroscience
- A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration
- (2013) Boxun Lu et al. FASEB JOURNAL
- Polyglutamine Disease Toxicity Is Regulated by Nemo-like Kinase in Spinocerebellar Ataxia Type 1
- (2013) H. Ju et al. JOURNAL OF NEUROSCIENCE
- Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
- (2012) Richard Grondin et al. BRAIN
- Nemo-like kinase, a multifaceted cell signaling regulator
- (2012) Tohru Ishitani et al. CELLULAR SIGNALLING
- Network Organization of the Huntingtin Proteomic Interactome in Mammalian Brain
- (2012) Dyna I. Shirasaki et al. NEURON
- Identifying polyglutamine protein species in situ that best predict neurodegeneration
- (2011) Jason Miller et al. Nature Chemical Biology
- Control of autophagy as a therapy for neurodegenerative disease
- (2011) Harry Harris et al. Nature Reviews Neurology
- Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
- (2011) Yong Cheng et al. NEUROIMAGE
- Huntington's Disease: Can Mice Lead the Way to Treatment?
- (2011) Zachary R. Crook et al. NEURON
- Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins
- (2011) David C. Butler et al. PROGRESS IN NEUROBIOLOGY
- Clearance of Mutant Proteins as a Therapeutic Target in Neurodegenerative Diseases
- (2010) Dimitri Krainc ARCHIVES OF NEUROLOGY
- Acute Polyglutamine Expression in Inducible Mouse Model Unravels Ubiquitin/Proteasome System Impairment and Permanent Recovery Attributable to Aggregate Formation
- (2010) Z. Ortega et al. JOURNAL OF NEUROSCIENCE
- Proteasomal dysfunction in aging and Huntington disease
- (2010) Xiao-Jiang Li et al. NEUROBIOLOGY OF DISEASE
- IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
- (2009) Leslie Michels Thompson et al. JOURNAL OF CELL BIOLOGY
- Nemo-Like Kinase, an Essential Effector of Anterior Formation, Functions Downstream of p38 Mitogen-Activated Protein Kinase
- (2009) E. Ohnishi et al. MOLECULAR AND CELLULAR BIOLOGY
- Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies
- (2008) S Sarkar et al. CELL DEATH AND DIFFERENTIATION
- Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
- (2008) Wenzhen Duan et al. NEUROBIOLOGY OF DISEASE
- The Ubiquitin-Proteasome Pathway in Huntington's Disease
- (2008) Siddhartha Mitra et al. TheScientificWorldJOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started